Virogenomics
Virogenomics BioDevelopment, based in Portland, aids in transitioning early-stage biotech innovations from labs to market, ensuring maximum impact.
Founded
2001Virogenomics BioDevelopment, based in Portland, aids in transitioning early-stage biotech innovations from labs to market, ensuring maximum impact.
Virogenomics BioDevelopment, founded in Portland, focuses on transitioning early-stage biotech innovations from the lab to the marketplace. Their core mission is to bridge the gap between scientific discovery and commercial success. They collaborate with technology leaders at universities and small biotech companies to assess the full potential of their technologies and develop strategies for market entry. Their services include scientific, regulatory, and funding expertise to ensure successful commercialization.
Notable affiliates include experienced professionals in biotechnology and regulatory affairs, though specific names are not provided. Virogenomics BioDevelopment has achieved significant milestones in facilitating the market entry of various biotech innovations, impacting both the academic and commercial sectors. Their overall impact lies in accelerating the development and commercialization of groundbreaking biotech solutions, thereby contributing to advancements in healthcare and related fields.
Companies similar to Virogenomics include Accelerator Life Science Partners, Precision Virologics, LifeX and Agile Sciences.
Virogenomics was founded in 2001.
Virogenomics' headquarters is located in Portland, OR, US.
As of Jan 1, 2018, Virogenomics has disclosed funding of $587.4k (USD). Undisclosed round amounts are excluded.
Virogenomics has 30 employees as of Feb 5, 2024.
Agile Sciences
agilesci.com
